This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...

The oral TLR 7/8 inhibitor showed clinically meaningful improvement in disease activity for patients with active lupus rash in a phase 2 study.

Lupus rash can lead to physical discomfort and emotional distress, highlighting the need for effective treatments to manage its signs and symptoms; Not intended for UK-, US- or Canada-based media ...

Merck KGaA (Merck)’s investigational lupus therapy enpatoran will be advancing to Phase III trials after meeting the primary endpoint in one cohort but missing it in another. While the drug met ...

The findings from Cohort A of the study were presented at the 16th International Congress on Systemic Lupus Erythematosus (LUPUS 2025), which is being held in Toronto from May 21-24. Enpatoran was ...

The findings from Cohort A of the study were presented at the 16th International Congress on Systemic Lupus Erythematosus (LUPUS 2025), which is being held in Toronto from May 21-24.

Enpatoran shows promising efficacy in lupus rash Merck’s investigational oral TLR7/8 inhibitor significantly improved skin disease activity in patients with cutaneous and systemic lupus erythematosus, ...

World Lupus Day 2025: Genetics, environmental triggers like sunlight and infections, stress, and hormonal fluctuations all play roles in its onset and progression. Its symptoms can resemble those ...

What it looks like: Fifth Disease is caused by Parvovirus B19 and presents with a red rash on the cheeks, arms, and legs that can last for several weeks. This condition occurs most often in children.

Topical mupirocin lowers lupus inflammation Date: January 29, 2025 Source: Michigan Medicine - University of Michigan Summary: Systemic lupus erythematosus commonly presents as a rash.

Cancer Survivor Chhavi Mittal Suffers From Lupus Rash: "I Have 100 Of Spots On My Body Now" facebook. ... (SLE) rash has reappeared. She shared a series of photos on social media.